304 related articles for article (PubMed ID: 32168867)
1. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
[No Abstract] [Full Text] [Related]
2. Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses.
Baumert TF; Schuster C; Cosset FL; Dubuisson J; Hofmann M; Tautz N; Zeisel MB; Thimme R
J Hepatol; 2016 Apr; 64(4):968-73. PubMed ID: 26780288
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus.
Pietschmann T; Brown RJP
Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
[TBL] [Abstract][Full Text] [Related]
4. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
[No Abstract] [Full Text] [Related]
5. The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses.
Lanford RE; Evans MJ; Lohmann V; Lindenbach B; Gale M; Rehermann B; Chang KM; Lemon SM
Gastroenterology; 2009 Jan; 136(1):9-16. PubMed ID: 19026648
[No Abstract] [Full Text] [Related]
6. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies.
Ramirez S; Bukh J
Antiviral Res; 2018 Oct; 158():264-287. PubMed ID: 30059723
[TBL] [Abstract][Full Text] [Related]
7. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
8. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
9. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
Shi J; Li Y; Chang W; Zhang X; Wang FS
Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
11. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus Infection in the Older Patient.
Reid M; Price JC; Tien PC
Infect Dis Clin North Am; 2017 Dec; 31(4):827-838. PubMed ID: 29079161
[TBL] [Abstract][Full Text] [Related]
13. Animal models for the study of hepatitis C virus infection and related liver disease.
Bukh J
Gastroenterology; 2012 May; 142(6):1279-1287.e3. PubMed ID: 22537434
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.
Ray RB; Ray R
Hepatology; 2019 Feb; 69(2):889-900. PubMed ID: 30102776
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity against hepatitis C virus.
Xu Y; Zhong J
Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
[TBL] [Abstract][Full Text] [Related]
16. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
17. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
18. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
19. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
[TBL] [Abstract][Full Text] [Related]
20. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
